Astellas Pharma Inc.

¥2,472As of Sun 8 Nov 2026, 12:00 UTC
TSE:4503Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 7.93%
Div yield 3.24%
ROE 21.44%
Drug Manufacturers (General)
Beta (5Y) 0.04
PE TTM 11.52
TSR TTM 58.19%
Mkt cap ¥4.432T
ROIC 17.34%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥2,630
6.43%
(26.63%)
Hold 11|1|4|11|8
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
49.92
54.07
58.77
62.32
10.78%
15.53%
17.66%
18.66%
Revenue¥B
228.2
233.2
241.8
252.7
2.01%
4.53%
3.27%
9.63%
Peers (US$28.14B)
Cap (US$)
PE
38.54B
15.74x
36.71B
106.3x
Capital
TTM
5Y
10Y
Leveragex
0.901
(0.028)
(0.022)
EBIT/Intx
11.50
0.045
0.042
Own earn%
(13.64)
11.77
5.02
Sh yield%
27.45
22.32
19.05
Owners
Insiders/Inst%
14.28
34.63
Short interest%
3.47
SBC / revenue%
3.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
19–24
$1 testx
—
Incr. ROIC%
21